Raymond James Financial
BSX icon

Raymond James Financial’s Boston Scientific BSX Stock Holding History

Raymond James Financial’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$190M Sell
3,029,097
-503,955
-14% -$40.3M 0.06% 289
2025
Q4 		$337M Buy
3,533,052
+375,845
+12% +$36.8M 0.1% 162
2025
Q3 		$308M Buy
3,157,207
+779,938
+33% +$80.8M 0.1% 185
2025
Q2 		$255M Buy
2,377,269
+199,932
+9% +$20.2M 0.09% 210
2025
Q1 		$220M Buy
2,177,337
+41,422
+2% +$4.17M 0.08% 224
2024
Q4 		$191M Buy
+2,135,915
New +$188M 0.07% 249

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Raymond James Financial's BSX Position: Q1 2026 in Review

Raymond James Financial reduced its Boston Scientific (BSX) stake by 14% in Q1 2026, selling an estimated $40.3M and leaving 3,029,097 shares worth $190M. The position accounts for 0.06% of the portfolio, ranked #289.

Raymond James Financial first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $337M in Q4 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Raymond James Financial held 3,029,097 shares of Boston Scientific worth $190M as of Q1 2026.
  • Raymond James Financial sold 503,955 Boston Scientific shares in Q1 2026, an estimated $40.3M.
  • Boston Scientific made up 0.06% of Raymond James Financial's portfolio in Q1 2026, its #289 holding.
  • Raymond James Financial first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Boston Scientific position peaked at $337M in Q4 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.